成人住院患者院内心搏骤停早期预警指标的构建
本研究旨在建立供中国护士识别成人住院患者院内心搏骤停(IHCA)的早期预警指标。研究组检索中英文数据库及指南网站至2020年6月30日,经文献调研和专家组分析拟定专家函询问卷,于2022年7月至9月选取北京、天津、吉林、山东、陕西、四川、浙江等三级甲等综合医院的32名医疗和护理专家,采用德尔菲法进行两轮函询。两轮有效应答率分别为100%(32/32)和93.75%(30/32),Kendall协调系数W分别为0.340和0.462,专家权威系数Cr分别为0.88和0.89,重要性赋值均值分别为3.94~5.00和4.07~5.00,变异系数分别为0~0.16和0~0.14,差异均有统计学意义(均P<0.05)。最终形成包含生命体征、意识与瞳孔、术后血性引流量、实验室结果、症状与主诉五个方面的5项一级指标、23项二级指标和43项三级指标。
要点
- 最终构建的IHCA早期预警指标体系包括5项一级指标、23项二级指标和43项三级指标,涵盖生命体征、意识与瞳孔、术后血性引流量、实验室结果、症状与主诉五个方面。
- 两轮专家函询有效应答率分别为100%(32/32)和93.75%(30/32),专家权威系数Cr分别为0.88和0.89。
- 两轮Kendall协调系数W分别为0.340和0.462,重要性赋值均值分别为3.94~5.00和4.07~5.00,变异系数分别为0~0.16和0~0.14,差异均有统计学意义(均P<0.05)。
- 该指标体系适用于帮助护士尽早发现成人住院患者病情变化,以识别IHCA风险。
适用人群与场景
- 成人住院患者,用于护士识别院内心搏骤停(IHCA)的早期预警。
研究设计与关键结果
- 研究类型为德尔菲专家函询研究,选取北京、天津、吉林、山东、陕西、四川、浙江等三级甲等综合医院的32名医疗和护理专家,于2022年7月至9月进行两轮函询。
- 初步形成包含生命体征、意识与瞳孔、术后血性引流量、实验室结果等方面的5项一级指标、23项二级指标和41项三级指标。
- 两轮专家函询有效应答率分别为100%(32/32)和93.75%(30/32)。
- 第一轮和第二轮Kendall协调系数W分别为0.340和0.462,专家权威系数Cr分别为0.88和0.89。
- 第一轮和第二轮重要性赋值均值分别为3.94~5.00和4.07~5.00,变异系数分别为0~0.16和0~0.14,差异均有统计学意义(均P<0.05)。
- 最终形成5项一级指标、23项二级指标和43项三级指标,包括生命体征、意识与瞳孔、术后血性引流量、实验室结果、症状与主诉五个方面。
证据类型、等级与局限
- 证据类型:德尔菲专家函询研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该指标体系适用于帮助护士尽早发现成人住院患者病情变化,以识别IHCA风险;作者认为专家函询意见趋于一致且具有科学性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To establish early warning indicators for Chinese nurses to recognize in-hospital cardiac arrest (IHCA) of adult inpatients.
METHODS: Computer retrieval of Chinese and English databases such as CNKI, Wanfang Database, VIP, National Medical Library of the United States PubMed Database, Web of Science, Embase Database of the Netherlands Medical Abstracts, Cochrane Library Database and other international guidelines collaboration network (GIN), National Institute for Health and Clinical Optimization (NICE), Scottish Intercollegiate Guidelines Network (SIGN), BMJ best clinical practice and other guidelines was performed. The retrieval time limit for respiratory and cardiac arrest early warning indicators or risk identification related content of the adult inpatient in the professional website was until June 30, 2020. After literature research and expert group analysis, the research group drew up an expert correspondence questionnaire, and selected 32 medical and nursing experts from Beijing, Tianjin, Jilin, Shandong, Shaanxi, Sichuan, Zhejiang and other grade three first-class general hospitals from July to September 2022. The Delphi method was used to conduct two rounds of expert correspondence, forming the final version of the early warning index of cardiac arrest in adult inpatients.
RESULTS: Five first-level indicators, 23 second-level indicators and 41 third-level indicators including vital signs, consciousness and pupils, postoperative blood drainage volume, lab results and other five aspects were initially formed. The effective response rates of the two rounds of expert correspondence were 100% (32/32) and 93.75% (30/32), respectively, the Kendall coordination coefficients W of the first round and the second round were 0.340 and 0.462, respectively, the expert authority coefficients Cr were 0.88 and 0.89, respectively, the mean value of importance assignment was 3.94-5.00, 4.07-5.00, and the coefficient of variation was 0-0.16, 0-0.14, with statistically significant differences (all P < 0.05). Finally, 5 primary indicators, 23 secondary indicators and 43 tertiary indicators were formed, including five aspects of vital signs, consciousness and pupils, postoperative blood drainage, lab results, symptoms and chief complaints.
CONCLUSIONS: The expert consultation on the early warning indicators of IHCA for adult patients tends to be consistent and scientific, which is applicable to help nurses detect the changes of patients' condition as early as possible.
参考来源
- Wang Y, Zhang Z, Xia X, et al. [Construction of early warning indicators of in-hospital cardiac arrest in adult inpatients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567577. doi:10.3760/cma.j.cn121430-20221017-00925
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。